SLC30A8 rs4402656: Beta-Cell Function and Diabetes Risk
The genetic variant rs4402656 is an intronic single-nucleotide polymorphism located within the SLC30A8 gene on chromosome 8. SLC30A8 encodes zinc transporter 8 (ZnT8), a specialized transport protein essential for insulin packaging and secretion within pancreatic beta cells. In human association studies, rs4402656 has been investigated for modest statistical links with glycemic traits, beta-cell function, and altered susceptibility to type 2 diabetes.
What each genotype means
Typical risk profile
You carry two copies of the G allele in the SLC30A8 gene. In published genome-wide association studies, this background genotype is not associated with the increased risk of type 2 diabetes or alterations in beta-cell insulin secretion seen with the A allele. However, type 2 diabetes is a complex trait influenced by many genes and lifestyle factors.
Carried by approximately 40% to 50% of individuals in European and East Asian populations, and it is more common in African populations.
Slightly increased diabetes risk
You carry one copy of the A risk allele and one copy of the G allele in the SLC30A8 gene. Population studies report a modest statistical increase in susceptibility to type 2 diabetes and subtle differences in pancreatic beta-cell insulin processing compared to individuals with two G alleles. This small genetic effect does not diagnose diabetes or determine individual clinical outcomes.
Carried by approximately 40% to 48% of individuals of European ancestry and roughly 35% to 45% of individuals of East Asian ancestry.
Elevated susceptibility to type 2 diabetes
You carry two copies of the A risk allele in the SLC30A8 gene. Research associations indicate a modestly higher statistical risk for type 2 diabetes and reduced beta-cell secretory response compared to other genotypes at this locus. While this genotype confers a higher relative risk at this single marker, overall metabolic health is predominantly shaped by broader lifestyle and polygenic factors.
Carried by approximately 10% to 15% of people of European ancestry and occurs at lower rates in African populations.
Genomic Context and the rs4402656 Variant
The single nucleotide polymorphism rs4402656 sits on the long arm of human chromosome 8 (8q24.11) within an intronic region of the solute carrier family 30 member 8 (SLC30A8) gene. Because it is an intronic variant, rs4402656 does not alter the primary amino acid sequence of the resulting protein. Instead, variants in this non-coding segment of SLC30A8 frequently serve as genetic markers or regulatory candidates that exist in linkage disequilibrium with other nearby polymorphisms across the SLC30A8 locus. Standard reference records classify rs4402656 as a common bi-allelic single nucleotide exchange involving guanine (G) and adenine (A) alleles. In genome-wide association studies (GWAS), this locus has been repeatedly analyzed alongside coding variants like rs13266634 to dissect how variation in the SLC30A8 genomic region alters human pancreatic islet physiology and downstream glucose homeostasis.
Biological Role of the SLC30A8 Zinc Transporter
The SLC30A8 gene encodes zinc transporter 8 (ZnT8), a transmembrane transport protein expressed at very high levels in the endocrine pancreas, especially within the insulin-producing beta cells of the islets of Langerhans. During insulin biosynthesis, ZnT8 mediates the movement of divalent zinc ions from the cytoplasm into intracellular insulin secretory granules. Within these granules, zinc is required to crystallize insulin monomers into solid hexamers, facilitating the stable, dense storage of large quantities of insulin prior to release. When blood glucose rises, these granules fuse with the plasma membrane to release both insulin and zinc into the circulation. Disruption or subtle alterations in ZnT8 expression or activity can alter islet zinc accumulation, modifying insulin maturation, granule packaging efficiency, and glucose-stimulated insulin release.
Research Evidence and Clinical Interpretation
The current catalog evidence strength for rs4402656 is classified as limited. While large-scale meta-analyses and genome-wide association cohorts establish that common variation in SLC30A8 is statistically linked to type 2 diabetes risk and measures of beta-cell function, individual non-coding single-nucleotide variants like rs4402656 generally carry modest effect sizes. For example, the effect of common alleles at this locus rarely shifts individual relative risk by more than a few percentage points. Furthermore, because rs4402656 is closely linked to other functional and missense variations within SLC30A8, researchers debate whether it exerts direct regulatory effects on transcription or simply tags adjacent functional haplotypes. Unlike rare, high-impact loss-of-function nonsense mutations that confer significant protection against type 2 diabetes, common polymorphisms like rs4402656 are polygenic contributors rather than deterministic clinical predictors.
What Consumers Can and Cannot Conclude
Discovering your rs4402656 genotype provides educational insight into polygenic traits, but it cannot diagnose or rule out type 2 diabetes or any other medical condition. Common genetic variants account for only a fractional portion of an individual's total metabolic risk. Lifestyle factors—including physical activity, nutrition, sleep quality, and body composition—alongside broader family history, exert a far larger influence on metabolic health than any single SNP. Testing positive for an associated allele does not mean an individual will develop impaired glucose tolerance, nor does a protective genotype guarantee immunity. Readers should never alter prescription medications or start targeted supplements based on this genotype, but should instead consult a qualified healthcare provider or certified genetic counselor for clinical evaluation.
How common is this variant?
The minor A allele occurs at an estimated frequency of approximately 30% to 35% in European ancestry populations, with variable frequencies reported across global ethnic cohorts in large aggregate sequencing datasets.
Frequently asked questions
Does having the rs4402656 variant mean I will get type 2 diabetes?
No. The rs4402656 variant is a common single nucleotide polymorphism associated with modest statistical differences in population studies, not a deterministic cause of disease. Type 2 diabetes is a complex condition driven primarily by lifestyle factors, overall health, and many hundreds of interacting genetic variants.
What is the function of the SLC30A8 gene?
SLC30A8 encodes zinc transporter 8 (ZnT8), a specialized membrane protein responsible for moving zinc ions into insulin storage granules within pancreatic beta cells. This zinc transport is critical for packaging and crystallizing insulin so that it can be stored and secreted effectively.
Is rs4402656 a coding mutation in the ZnT8 protein?
No, rs4402656 is an intronic variant, meaning it is located within a non-coding sequence of the SLC30A8 gene. It does not directly change any amino acids in the ZnT8 transporter, but it may reflect regulatory activity or co-inherit with nearby coding variants.
Should I take zinc supplements based on my rs4402656 genotype?
No, there is currently no clinical evidence supporting zinc supplementation based on an individual's rs4402656 genotype. Dietary supplements should be discussed with a healthcare provider who can evaluate your overall nutritional status and metabolic health.
Sources & further reading
Educational information only, last refreshed 9/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4402656?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29